NFATc1 controls the cytotoxicity of CD8+ T cells

Cytotoxic T lymphocytes are effector CD8 + T cells that eradicate infected and malignant cells. Here we show that the transcription factor NFATc1 controls the cytotoxicity of mouse cytotoxic T lymphocytes. Activation of Nfatc1 −/− cytotoxic T lymphocytes showed a defective cytoskeleton organization and recruitment of cytosolic organelles to immunological synapses. These cells have reduced cytotoxicity against tumor cells, and mice with NFATc1-deficient T cells are defective in controlling Listeria infection. Transcriptome analysis shows diminished RNA levels of numerous genes in Nfatc1 −/− CD8 + T cells, including Tbx21 , Gzmb and genes encoding cytokines and chemokines, and genes controlling glycolysis. Nfatc1 −/− , but not Nfatc2 −/− CD8 + T cells have an impaired metabolic switch to glycolysis, which can be restored by IL-2. Genome-wide ChIP-seq shows that NFATc1 binds many genes that control cytotoxic T lymphocyte activity. Together these data indicate that NFATc1 is an important regulator of cytotoxic T lymphocyte effector functions. NFAT nuclear translocation has been shown to be required for CD8 + T cell cytokine production in response to viral infection. Here the authors show NFATc1 controls the cytotoxicity and metabolic switching of activated CD8 + T cells required for optimal response to bacteria and tumor cells.